• Testing is more important than ever, medical experts claim, urging government to speed up widespread testing
• Tens of millions of rapid, at-home tests may be needed every day
• UME offers rapid testing kits to help end the pandemic, ready to seize the opportunity

The U.S. government has announced plans to roll out more than 60 million home test kits to stop the COVID-19 virus from spreading (https://ibn.fm/O89KJ). United Medical Equipment Business Solutions Network (“UME”), a company offering a comprehensive line of COVID-19 products including rapid testing kits, stands ready to capitalize on the growing push for widespread testing and help slow the global pandemic.

Health experts agree with the new administration’s commitment to widespread rapid testing, but some fear that officials do not respond quickly enough. “Testing is actually more important now than it was eight months ago because of the high contagiousness rate of these new variants,” says Mara Aspinall, a professor of health practice at Arizona State University, said in a recent interview for NPR. “It is critical to stop these new strains right in their tracks. And the only way to do that is to test.”

Identifying infected people through country-wide rapid testing could be vital for curbing the virus and preventing new variants from emerging. The country reportedly needs tens of millions of tests every day to avoid another surge, while it buys time to get enough people vaccinated. “The virus still has an impressive grip on us. We need to be scaling these [tests] up today.”, said Dr. Michael Mina, an infectious disease epidemiologist at the Harvard T.H. Chan School of Public Health, in the article. Dr. Mina urges the Food and Drug Administration to approve more simple, rapid, inexpensive tests. They can be made quickly, thus enabling frequent testing of people at their homes.

Widespread rapid testing could jumpstart testing rates that have been stagnating at 1.6 million a day. At-home tests could make up for shortages in supplies, and the often-long wait times that come with the gold-standard PCR testing.

Other countries have already implemented rapid at-home testing. For example, amid the surge in COVID-19 cases in early 2021, the UK government announced it would roll out millions of cheap, rapid virus tests — a potential game changer in the fight against the virus (https://ibn.fm/ngMgh).

As a company committed to providing essential services during the epidemic, UME offers a comprehensive COVID-19 monitoring toolset designed with the assistance of medical experts. It includes data-driven COVID-19 testing of people with or without symptoms and could be useful for testing those in close contact with someone who has the virus. The Company appears ideally positioned to benefit from the pent-up demand for the rapid test as the push for widespread testing continues to grow.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at  https://ibn.fm/UnitedMed

• Digital subscription platforms have become increasingly popular because they bridge the gap created by closing venues because of the pandemic
• Billboard Bulletin covers the future of live streaming, record labels, and the music industry – citing the experience of Patreon CEO Jack Conte, who has seen exponential growth in the last year
• Friendable’s application Fan Pass has seen 100% growth in live streaming events and artist performances in 2021
• Digital subscription platforms are driven by the superfans and Generation Z social media users and influencers

Although many digital subscription platforms were in existence prior to the monumental impact the pandemic made on the industry in 2020, many did not see unprecedented growth in subscription rates until then. Releasing a digital subscription for fans in 2020, mobile technology and marketing company Friendable (OTC: FDBL) has seen exponential and consistent growth since launching its platform for fans to gain exclusive access to the artists they love. A recent Billboard Bulletin article goes over the future of live streaming, record labels, and the music industry. Available only to paid subscribers at https://ibn.fm/O4JMW, the article quotes Patreon CEO Jack Conte as saying that “the last year has shown artists that subscription platforms are another revenue stream that they can develop in addition to touring and used to offer exclusive content tide to their live shows.” Patreon was founded in 2013 and pioneered the subscription membership platform industry. The company is popular due to its creator-friendly revenue splits. Friendable has already seen a 100% growth in live stream events and artist performances in 2021. In a press release, Friendable’s CEO Robert A. Rositano Jr. said that metrics mean everything – whether they show an increase or a decrease, and that the metrics the company sees guide the teams on the Fan Pass journey (https://ibn.fm/lxN7h). “I am happy to report that Fan Pass is being embraced on all fronts in more ways than I could have imagined,” Rositano Jr. added. “An active community breeds additional activity, content growth and fan engagement, which all feeds the subscription revenue model, artist ticket/event sales and overall merchandise exposure for additional e-commerce revenue. In addition, we believe the convergence of all these advances together will bring Fan Pass closer to attracting its first sponsor and open the door to additional revenue opportunities that are now becoming even clearer.” The Fan Pass platform is a mobile technology and marketing platform designed to help artists engage with their fans worldwide and earn revenue while doing so. Fan Pass brings an “all-access” VIP experience that includes:

• Live performances and online concerts
• Backstage meet & greets before and after the pay-per-view events
• Livestreamed content of studio sessions
• Behind-the-scenes footage of music videos and photoshoots
• Special interviews and one-on-one video
• Streams that highlight the daily lives of the artist

The subscription to the platform starts at $3.99 and provides single-purchase pay-per-view exclusive content like concerts for fans. With the closure of most live music venues worldwide, Fan Pass was designed to help bridge the gap left by the pandemic by enabling connection and engagement between artists and fans. The Billboard Bulletin article also points out that digital subscription platforms that fill the void left by the pandemic are coming off of 12 months of unprecedented subscriber growth due to the high number of artists that joined the platforms. The subscriptions are the equivalent of real-time fan clubs for members of Generation Z who have grown up with micropayments and maintaining multiple subscriptions for media and entertainment. The fan clubs of today are more engaged than they were 20+ years ago when you sent a letter and hoped for an autograph in return. Fans expect exclusive material, VIP tickets, rare merchandise items, and virtual concerts, the article underlines. The reach that subscription platforms have is partially due to the rise of social media and influencers. These have bred the perfect environment to create superfans, which are more impactful thanks to social media use. Artists are inspired and motivated by the superfans because they are often more a part of the artist’s world than the artists themselves. Friendable and Fan Pass are leveraging their success on fans’ desire to gain instant access to the artists they love. Future artists will now cultivate their skills through entrepreneurial qualities, not rely on the traditional record companies to pave a path they can’t recoup from. Revenue streams are readily available through the digital subscription services providing labels and artists access to first-line data that can be used to provide real value and capture a piece of the media budget, the Billboard Bulletin article also notes. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• High Pressure Processing (“HPP”) has become a highly successful method to reduce pathogens and extend shelf-life in food and beverages while maintaining taste, nutrition, flavor, and texture
• The HPP food and beverage market was estimated at $15.5 billion in 2019
• PBI’s UST process combines benefits of HPP with high shear and controlled temperature to achieve effective anti-microbial effects and long-term preservation with reduced or no chemicals
• Academia-Industry partnership will give global food companies in Consortium an early look and first-hand use of UST, with a right to non-exclusively license UST for their own commercial use
• This revolutionary, transformative technology is not just applicable to the massive food and beverage markets, but to the pharmaceutical, nutraceutical, cosmetics, and agriculture markets
• The Consortium resulted from research initially sponsored by the USDA NIFA

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative, pressure-based solutions for the worldwide life sciences and other industries, and the College of Food, Agricultural, and Environmental Sciences (“CFAES”) at The Ohio State University (“Ohio State”) announced a wide-ranging agreement for the implementation of PBI’s patented Ultra Shear Technology(TM) (“UST”) platform. PBI is developing three different models of the UST processing instrument, named the BaroShear: a small footprint benchtop model, a medium capacity floor model, and an industrial scale, continuous flow model for high capacity. All three models are designed to perform high shear processing of liquids under controlled temperatures and pressure conditions. They will be set up for demonstration and hands-on use in the world-renowned Ohio State food pilot plant (https://ibn.fm/BxEdd).

PBI is a leader in development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food/beverage industries. Together with Ohio State, whose CFAES is a globally recognized leader in the food sciences, PBI has formed a food industry consortium to advance the commercialization of its UST platform through the quality enhancement of beverages, condiments, sauces, and other liquid foods. Consortium members will have access to the UST technology in the Ohio State pilot plant and first rights to license all new UST applications developed through the Consortium.

The primary goals of the Consortium are:

• Develop and improve new commercial applications of UST
• Help address potential regulatory issues through scientific support
• Allow global food companies worldwide to experience UST product development and pre-commercialization efforts first-hand

Additionally, Consortium members will be rewarded with “first-look” opportunities to all new UST developments and first rights to non-exclusively license all new applications for commercial purposes.

According to Pressure BioSciences President and CEO Richard T. Schumacher, the Consortium will welcome a global group of preeminent leading food and beverage companies as members. “Each will contribute annually towards the Consortium’s operations, with funds supporting R&D at both PBI and Ohio State while participating as an advisory council to nominate, prioritize and direct UST applications development amongst the myriad opportunities that invite our attention,” he explained.

Food companies worldwide will have access to the Consortium, and members will help direct the scientific effort of OSU and PBI across prospective liquid food and beverage projects. The current topics of interest include:

• Spore inactivation and control of other pathogen and spoilage factors
• Enhancement of taste, smell, and other sensory qualities in liquid foods
• Formation of highly stable products that are suitable for ambient temperature storage, transportation, and distribution

Over the last two decades, high pressure processing (“HPP”) has established itself as a very successful clean-label (reduced or no chemical additives) approach for food safety and improved product life, according to PBI Senior Vice President of Engineering Dr. Edmund Y. Ting. As a result, the high pressure processing (“HPP”) food market reached $15.5 billion in 2019 and is expected to increase substantially through 2025 (https://ibn.fm/sY5RY). The HPP market makes some (not all) food safer, more stable, more nutritious, better tasting, and with fewer chemicals (clean label).

According to Dr. Edmund Ting, Sr. VP of Engineering at PBI and a pioneer in the development of HPP, “HPP has proven to be very effective in reducing food-borne pathogens and extending shelf-life in pre-packaged foods (e.g., juices and ready-to-eat meats), thus eliminating the need for chemical additives. However, because it is only a pasteurization process, and does not render food “commercially sterile”, HPP-processed food must be shipped, stored, and maintained under refrigeration throughout the entire chain of distribution and retail sale. We believe that Ultra Shear Technology will provide economical solutions to these problems, and will offer an additional, clean label processing choice to both consumers and the food industry around the world.”

The potential of UST is not just limited to food and beverages. Through this revolutionary platform, vitamins and cannabinoids could be infused into beverages, remaining in them without precipitating out, as is often seen today. Gels, creams, ointments, and other lotions could penetrate the skin faster and more completely, bringing the active ingredient to where it needs to be faster and with higher bioavailability. Vaccines and therapeutics could be enhanced and improved. The applications and benefits are seemingly endless.

PBI and Ohio State gratefully acknowledge the initial research support by the USDA NIFA, which resulted in the Consortium.

For more information, visit the company’s website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• Berubicin is CNS Pharmaceuticals’ lead product candidate for treatment of Glioblastoma Multiforme, and has the potential to be the first anthracycline to cross the blood-brain barrier based on limited results from a Phase 1 trial
• The market for GBM treatment is estimated to reach $3.3 billion in 2024, growing at a CAGR of 17.4%
• CNS, in collaboration with sublicensee partner WPD Pharmaceuticals, is currently planning three Berubicin clinical trials, all to start within the year – two Phase II adult trials and a pediatric Phase I trial

Glioblastoma Multiforme (“GBM”) is one of the most aggressive forms of brain cancer in the adult population and is currently considered incurable, with a significant recurrence rate in most patients. Even with gross total resection of the GBM tumor, there is always a microscopic amount of disease that gets left behind. A gross total resection of GBM is defined as removing at least 98% or more of the tumor that has been contrast-enhanced and visible on an MRI.

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company that is currently specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, hopes to address this issue and improve the lives of GBM patients while also lowering recurrence risks with its lead drug candidate, Berubicin.

Developed by Dr. Waldemar Priebe, Ph.D., the Chairman of the Scientific Advisory Board for CNS Pharmaceuticals, and a Professor of Medicinal Chemistry at the University of Texas MD Anderson Cancer Center, Berubicin appears (based on limited Phase 1 trial results) to be the first anthracycline to cross the blood-brain barrier (“BBB”) in adults, reaching the tumor’s cancerous cells. Anthracyclines are among some of the most effective drugs ever created for cancer treatment. They have various uses within cancer treatments, including breast, stomach, uterine, ovarian, bladder, lung, and hematological malignancies. To date, there has not been any evidence that anthracyclines can cross the BBB.

In December 2020, the U.S. Food and Drug Administration (“FDA”) cleared CNS Pharmaceuticals’ investigational new drug (“IND”) application. This approval enables the company to begin a human trial and ship Berubicin across state lines to clinical investigators.

CNS Pharmaceuticals is optimistic about the three upcoming clinical trials that are scheduled for Berubicin, and is enthusiastic about the first pediatric study that will begin later this year in Poland under the oversight of sublicensee partner WPD Pharmaceuticals. WPD will also be running a concurrent adult Phase II trial in Poland, while CNS Pharmaceuticals will organize a separate randomized, controlled Phase II adult trial beginning in the United States but slated to expand into western Europe.

Commenting on the plans for the Berubicin development program during a podcast interview with Sid Vaidaya and Eric Gershey, CNS Pharmaceuticals CEO John Climaco said, “This is the biggest news we’ve announced since our IPO back in November 2019. Based on that IND approval, we expect, in the next 90 to 120 days, we will go from zero active clinical trials today to three active clinical trials” (https://ibn.fm/4azlQ).

The market for GBM treatment has grown exponentially over the last few years, being expected to reach $3.3 billion by 2024, from $659 million in 2014 (https://ibn.fm/XOkXw). There are multiple companies making progress in this market as a result of increased focus and investment into research and development of GBM therapeutics. With Berubicin’s apparent ability to breach the BBB and the planned Phase I and Phase II trials, CNS Pharmaceuticals is uniquely positioned to capitalize on this market growth and secure a leading role in the sector.

For more information, visit the company’s website at www.CNSPharma.com

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

• Ideanomics’ Mobility and Capital divisions provide shareholders with access to disruptive and high-growth opportunities
• The company’s primary shareholders include two billionaire families – former chairman Dr. Bruno Wu and Vice Chairman Mr. Shane McMahon
• The company has raised approximately $400 million in six months to fund new investments and acquisitions in revenue-based growth focused on EV and fintech companies
• Ideanomics Mobility consists of five companies and generates revenue from the entire EV ecosystem from vehicle and battery sales to financing, leasing and insurance, all the way through charging and energy services
• The EV market is expected to grow exponentially, driven by growing public acceptance and the current U.S. administration’s support as it works toward a 100% clean-energy economy
• Ideanomics Capital is focused on financial technologies and their disruptive potential across financial services, ranging from markets and digital assets to real estate

Ideanomics (NASDAQ: IDEX) is a global company facilitating the adoption of commercial electric vehicles and supporting next-generation financial services and fintech products. Ideanomics is currently divided into two divisions – mobility and capital. These divisions provide shareholders with access to disruptive and high-growth opportunities. The company expects 2021 to be another growth year after it raised approximately $400 million over the past six months. This funding has already been put to good use with acquisitions of Wireless Advanced Vehicle Electrification (“WAVE”) and Timios. With roughly $200 million still on the balance sheet, Ideanomics continues to look for new investments and acquisitions in revenue-based opportunities focused on EV and fintech businesses. Founded in 2004, Ideanomics is headquartered in New York, New York, with additional offices in Hangzhou, Beijing and Qingdao, China. Its current operations span the United States, China, Ukraine and Malaysia. Ideanomics Mobility Ideanomics Mobility is focused on the EV market. The global commercial EV market was valued at $34.7 billion in 2018 and is expected to grow at a CAGR of 39.9% through 2022 to reach a total of $132.73 billion (https://ibn.fm/pPrf4). According to a survey by Grand View Research, the global EV charging infrastructure market is also expected to grow and reach $144.97 billion in 2028, expanding at a CAGR of 33.4% from 2021 to 2028. This growth is expected to be driven by increased support of electric vehicles from the public, as well as the current U.S. administration, which has a goal of achieving a 100% clean-energy economy. The Ideanomics Mobility unit consists of five companies:

• Mobile Energy Global (“MEG”) – Wholly owned China-based service provider of the Sales-to-Finance-to-Charging (“S2F2C”) business model to assist commercial fleet operators on EV enablement. Recent sales include 2,000 units of D1, BYD’s custom electric ride-hailing vehicle.
• Medici Motor Works – Wholly owned North America division. MMW will develop zero-emissions specialty vehicles, trucks, buses and vans for the North American market.
• Wireless Advanced Vehicle Electrification (“WAVE”) – Wholly owned Utah-based commercial EV charging technology company with a specialized offering of in-ground wireless charging for commercial vehicles. WAVE’s chargers power the Antelope Valley Transportation Authority, the largest municipal EV bus system in the country. Its revenue for 2020 exceeded $7 million, and it boasts a robust pipeline for 2021 and beyond.
• Treeletrik – Majority investment in Malaysian-based OEM will service a high-demand market – electric delivery mopeds. Treeletrik has obtained certifications in Thailand and Indonesia, with orders secured for 2021. Its North American marketing program is expected to commence in 2021. As a part of the ESG initiative, one tree will be planted for every unit sold.
• Solectrac – Minority investment in California-based electric tractor company. Solectrac manufactures 100% electric tractors to benefit farmers, crops and the planet at a time when the agriculture market remains virtually unaddressed by EV solutions.
• Silk EV – Minority investment in hyper car and performance car design company, which provides access to the high-end battery and charging technology development ecosystem.

Ideanomics is generating EV revenue from its Sales to Financing to Charging (“S2F2C”) business model, which features three operating areas:

1. Vehicle and Battery Sales: Medici, Treeletrik and Solectrac cover three key market segments
2. Financing, Leasing and Insurance: Offering financial services to fleet customers, commission delivery and origination fee-based revenue
3. Charging and Energy Services: Offering charging as a service, battery swap programs and WAVE wireless charging products

Ideanomics Capital Ideanomics Capital is focused on providing disruptive fintech solutions across the entire board of financial services, ranging from financial markets to digital securities and assets to mortgages and more. More mainstream institutions and a growing number of companies have increased their digital securities services, along with institutional investments boosting bitcoin and the emergence of favorable regulatory developments, creating ample opportunities for widespread adoption of financial technologies. Additionally, the U.S. real estate industry is ripe for technologization, as it currently is fragmented, antiquated, opaque and largely untouched by tech innovation. However, the expanding market, with U.S. home sales expected to grow 21.9% in 2021, and the increased digitization of all business spaces are expected to promote a digital-first experience as the new industry standard this year and beyond (https://ibn.fm/DwsUv). The Ideanomics Capital unit consists of five companies:

• Timios – Wholly owned subsidiary bringing real estate into the 21st century by providing value-add, fee-based services addressing the title and closing process of home buying and mortgage transactions. Timios works to create transparency and efficiency within the market. Timios ended 2020 as a cash flow and EBITDA positive business.
• The Delaware Board of Trade (“DBOT”) – Wholly owned FINRA-regulated ATS and broker dealer based in Delaware.
• Liquefy – Minority investment bringing innovation to investment in real assets with blockchain technology by increasing efficiency in fractional ownership, lowering entry to investment barriers and unlocking liquidity in assets that were previously illiquid.
• Technology Metals Market (“TM2”) – Minority investment in UK company delivering a direct investment and trading market for technology metals with a newly accessible technology metals asset class for inventory diversification. The traded metals are 100% backed by physical metals.
• Intelligenta – Investment providing AI and machine learning solutions for financial institutions and regulators.

Management Team Alf Poor is Ideanomics’ Chief Executive Officer. He is a client-focused and profit-driven executive who has a track record of success in rapidly growing technology companies and large, multi-national organizations. Mr. Poor’s expertise includes business planning, financing and creating and implementing corporate governance policies, as well as handling management across organizations. His specialization is working with cross-border and multi-national startups. Before taking the CEO role at Ideanomics, he was the CEO for Global Data Sentinel. Conor McCarthy is the company’s Chief Financial Officer. He is a strategic and operationally oriented management-level professional. His extensive international experience is within the fintech, data science and advertising technology sectors. Mr. McCarthy has experience with public companies, PE, and VC-backed firms. His specializations are financial and management reporting, planning and analysis, financial modelling, performance metrics, KPIs, venture borrowing, Series A equity funding, ERP system implementation, international business operations, and acquisition due diligence and integration. Before joining Ideanomics, Mr. McCarthy most recently held a CFO position at OS33. Prior to that, he was CFO for Intent Media Inc. Kate Lam is the company’s Managing Director of Financial Products. She is highly regarded for her fixed income capital marketing skills across Asia and the United States. Ms. Lam has over 25 years of experience in the financial markets industry, dealing with many asset classes and clients. Having spent a few years in the fintech startup industry, her skills bridge the gap between traditional financial assets and new technological innovations. She has held senior management positions at Bear Sterns, Deutsche Bank and Standard Chartered Bank. Keith Byers is Ideanomics’ Senior Vice President of Operations. He has extensive experience managing strategic relationships with key clients and deepening the relationships through innovation and successful engagement strategies. Before Ideanomics, Mr. Byers was the Managing Partner and Head of Operations for Gain Theory. He has a Master of Arts – MA, Economics from Heriot-Watt University and a Master of Science – Economics from The University of Edinburgh. Tony Sklar is the company’s Senior Vice President of Investor Relations. He is a communication strategist and has worked for multi-faceted companies with global operations. Mr. Sklar handles omni-channel distribution using intelligence platforms and data insights for strategic planning, international expansion and marketing channels. His specialties include project management with digital strategy and transformation, ICO, marketing, blockchain and strategic partnerships. In addition to his role with Ideanomics, he is also a board member for the Delaware Board of Trade and the host and senior technology reporter for Far From TV. For more information, visit the company’s website at www.Ideanomics.com. NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

• LD Micro reconstitutes index to reveal 35.73% increase over 2020, 423 new listings for total of 1,189 companies
• Index includes US and Canadian companies with market cap between $50-300 million, average daily traded value of $50,000 in previous quarter
• LD Micro is subsidiary of SRAX, provider of Sequire SaaS investor analytics platform

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its Sequire SaaS platform, recently announced that its LD Micro subsidiary reconstituted its North American microcap index to reveal a 35.72% increase of 423 new listings for a total of 1,189 companies (https://ibn.fm/a7p3d).

LD screens companies based on selection criteria that include market cap, trading value, listing, and filing information. To qualify for inclusion on its list, companies must be listed in the United States or Canada, have a market cap between $50 million and $300 million, an average daily traded value of $50,000 in the last quarter, and a 10Q or 10K filed in the preceding calendar year (https://ibn.fm/4fQXR).

“I cannot believe what I’ve seen in the past year,” said Chris Lahiji, President of LD Micro (https://ibn.fm/jOYwN). “The LD Micro Index has more than tripled from its March 2020 lows. The tiniest public companies were also some of the biggest winners last year, and already year-to-date. As each day goes by, the Index becomes more and more consequential to the next generation of great companies.”

Lahiji founded LD Micro as an independent resource to the microcap world in 2006, growing it quickly to become the premier event platform in the space. Following the identification of potential synergies with Sequire – SRAX’s SaaS platform that unlocks investor intelligence for private companies – LD micro was acquired by SRAX in September of 2020.

“LD Micro is, without a doubt, one of the most well-known and respected brands in micro-cap,” said SRAX CEO and founder Christopher Miglino. “Chris Lahiji and his team have done an incredible job of creating a loyal community of investors and issuers.”

Sequire empowers public companies with critical insights into the activities of both retail and institutional investors, helping them create and activate successful campaigns aimed at increasing investor engagement. Since 2019, the SaaS platform has grown to over 3 million active users that include investors and traders from over 90 public companies (https://ibn.fm/L8hSO).

In addition to Sequire, SRAX focuses on building the largest and most reliable opted-in data sets that span a broad range of industry verticals. As the power of data continues to increase across the digital landscape, the Company continues to focus on its mission to provide brands and companies across the CPG, luxury, lifestyle and financial spaces with high-quality data that provides key, actionable insights integral to strategic marketing campaigns.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Share purchase agreement will result in Pac Roots acquiring all issued, outstanding shares of Grasstown
• “The Grasstown culture complements PacRoots’ foundation of variety and quality built on the West Coast,” says PACR CEO
• Pac Roots intends to continue — and strengthen — the strong reputation built by the Grasstown brand

Cannabis and motorcycles make an intriguing combination — a combo that Lords of Grasstown Holdings Ltd. has created a whole business around. And now Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) is getting in on the action. The Company recently announced the execution of a share purchase agreement with the shareholders of Lords of Grasstown that will result in Pac Roots acquiring all the issued and outstanding shares of Grasstown (https://ibn.fm/PiCMh). “PacRoots is thrilled to partner with such an incredible brand and story driven by artists with a passionate vision that resonates throughout a massive community,” said PacRoots’ president and CEO Patrick Elliott. “The creators, designers and marketers behind Lords of Grasstown have a truly unique and talented offering that will be invaluable to the PacRoots organization. The Grasstown culture complements PacRoots’ foundation of variety and quality built on the West Coast. This platform brings a tremendous following that embraces these attributes, which are well positioned to excel in BC and California’s West coast marketplaces.” Founded in 2011 and incorporated in 2013, Lords of Gastown is a lifestyle motorcycle brand that first started in the Pacific Northwest. The company filled a gap in the Harley-Davidson street wear and apparel offerings space and quickly landed on Brian Barnes of Barnes Harley-Davidson Canada. Today the company has built partnerships and collaboration with some of America’s oldest and strongest motorcycle brands and has established more than 80 wholesale accounts across North America as well as in Switzerland, Mexico, Australia, Indonesia and Japan. The company’s cannabis connection comes through founder and director Tyler Hazelwood, who has struggled with Crohn’s disease for more than two decades. “Without cannabis I would not be able to be a dedicated single father to my daughter, nor would I have been able to build these brands or ride my motorcycle across North America,” said Hazelwood. “Cannabis is without a doubt my biggest tool in managing Crohn’s symptoms. I feel a sense of obligation to share my experiences and passion in hopes I can help others with IBD.” Following the success of Lords of Gastown Motorcycle Lifestyle brand, the company launched its Lords of Grasstown Cannabis Culture brand in 2013. The brand offers simple, clean, yet edgy street wear apparel and products, including a CBD soap line. In 2015, Grasstown partnered with BC Cannabis Genetics Guru JB to add some of Canada’s highest testing medical cannabis strains to the line. Through the share purchase agreement, Pac Roots intends to continue — and strengthen — the strong reputation built by the Grasstown brand. Pac Roots began operations in 2012, with activities primarily directed toward exploration and development of mineral properties in Canada. Today, the Company is focused on cannabis and hemp cultivation, leveraging high-end genetics and specialized cultivars to produce top-quality products. For more information, visit the company’s website at www.PacRoots.ca. NOTE TO INVESTORS: The latest news and updates relating to PACR are available in the company’s newsroom at http://ibn.fm/PACR

• Industry leaders remain hopeful that 2021 will be positive year for uranium market
• Demand outstrips supply as global push for carbon-free energy source gains momentum amid muted supply
• As the leading U.S. uranium producer, Energy Fuels is ready to leverage growing market opportunity, remain at forefront of U.S. nuclear energy space

After years of stagnation, industry leaders are confident that the uranium market is going through a revival, heading for potentially rapid growth in the coming years. As a leading U.S. uranium producer, Energy Fuels (NYSE American: UUUU) (TSX: EFR) appears poised to seize on the growing calls for nuclear energy to be deployed to help address climate change and reduce air pollution.

Uranium prices have been depressed for several years, as demand dropped after the 2011 Fukushima disaster in Japan. However, supply shortages and the global quest for alternative, low-carbon power sources have renewed interest in this market.

A recent article published by “Investing News” cites industry leaders feeling optimistic about the direction of the market in 2021 on the back of the strong fundamentals that can drive robust growth. Increasingly recognized as an essential part of the clean energy mix, nuclear energy could significantly increase its share of global electricity production from the current 10%. Nuclear provides 20% of U.S. electricity, and 55% of the carbon-free electricity produced in the country.

The uranium price has increased by more than 20% over the past year to around $30 as longer-term fundamentals are expected to remain strong for the sector (https://ibn.fm/MTv5D). Based on cost-curve support calculations, the long-term sustainable uranium spot price is most likely in the $40–$50 per pound range with a potential multiyear spike to $80/lb, according to a recent industry research (https://ibn.fm/ag0AA).

The article features Energy Fuels vice president of marketing and corporate development Curtis Moore, who points out that years of stagnation have potentially led to uranium’s moment as demand continues to exceed supply. Inventory reduction, deposit depletion and continued high grading indicate the potential for strong price performance in the coming years.

Moore also notes that prices are still below the level needed to accelerate production. Despite activity increasing in 2020, there are still inventories available in the market, he notes, but they are being depleted and at some point will need to be replaced. This could happen at a price that incentivizes mine production, and this price is much higher than what we see reported today, he said.

“We think there are definitely better uranium markets ahead,” said Moore. “The realizable sales price for uranium is below most miners’ cost of production, which is unsustainable. In many ways, history is repeating, and we might be in the beginning of the next run in uranium prices. We don’t know when the market will recover, but it will.”

As a leading uranium producer, Energy Fuels appears well positioned to seize the market opportunity as the industry heads for a potential price surge.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• Online sales of new TAAT tobacco-free, nicotine-free option totals CDN$100,000 sales in only five days
• TryTAAT site launched on Feb. 17 with cartons of TAAT Original, Smooth and Menthol available for purchase
• “February has been a very productive month for us here at TAAT,” says CEO, citing list of achievements

Within the first five days of the launch of its e-commerce portal, TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) reported that its flagship product — TAAT(TM), a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol —had totaled more than CDN$100,000 in sales, with $48,000 of that coming in the first 48 hours (https://ibn.fm/cyc6O). Those numbers confirm what the TAAT team has known since the launch of the product only two months ago: legal-age smokers are eagerly looking for a nicotine- and tobacco-free smoking experience (https://ibn.fm/0mrwU). A life sciences company committed to providing that kind of smoking experience to adult smokers, TAAT lunched its e-commerce portal last Wednesday at 9 a.m. ET (https://ibn.fm/snLKs). Designed to allow smokers aged 21 years and older to purchase TAAT’s flagship product, the TryTAAT site has delivered beyond what TAAT management expected. “To sell more than CDN$100,000 worth of a relatively new product in such a short period is absolutely exceptional,” said TAAT CEO Setti Coscarella. “Countless smokers aged 21-plus in the United States have been eagerly awaiting the launch of our online store on Wednesday, which I believe has contributed significantly to our product sales this past week.” The site launched on Wednesday, with cartons of TAAT Original, Smooth and Menthol available for purchase by adult-age smokers and shipment to addresses in eligible jurisdictions. Shortly after the initial launch, a Taste Explorer Bundle was added to the site, consisting of one 20-stick pack of each of the three TAAT varities. In addition, the company’s TryTAATpromotion remains active, in which adult smokers in eligible states can request a complimentary sample pack of the TAAT variety of their choice. TAAT is pioneering a new concept with TAAT, its tobacco-free and nicotine-free smoking alternative. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. TAAT products were first unveiled in various retail locations throughout Ohio, where an estimated 60% of retailers who carried the product for at least three weeks have reordered at least once (https://ibn.fm/9W75P). “Our iterative rollout of TAAT in the United States has been very strategically planned to test the initial reactions of smokers aged 21-plus when introduced to the concept of a nicotine-free and tobacco-free smoking experience, while also gauging reception of the product after it is sampled for the first time,” said Coscarella. “Over the past two months, we have had the opportunity to gather quite a bit of feedback about TAAT from smokers aged 21-plus as well as retailers and wholesalers of tobacco. I believe those insights have proven useful, as they played a role in creating our strategies for launching the TAAT online store on Wednesday, which has been a remarkable success so far. . . . “February has been a very productive month for us here at TAAT,” he continued. “In addition to launching our e-commerce portal and selling over CDN$50,000 worth of TAAT in 48 hours, we also secured our engagement with a major CPG sales agency, landed our first mainstream nationwide media coverage in ‘Forbes,’ and boosted our manufacturing rate by 233%. All of our initiatives for bringing TAAT to market in the United States are strategically coordinated, and I believe that e-commerce plays a significant role in providing us the opportunity to sell TAAT to smokers aged 21+ all across the United States while complementing our Ohio retail activities and a nationwide rollout with the CPG sales agency set to begin next week.” Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry. For more information, visit the company’s website at www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• Company reports record gross revenues of C$1,089,502 last month
• “It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” states CEO
• Record revenue comes during one of slowest e-commerce periods of year, highlighting impact the company has in the plant-based marketplace

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) saw record gross revenues last month (https://ibn.fm/qro4v). The company released its monthly numbers, noting that gross revenues for January 2021 totaled a record-breaking C$1,089,502; cost of goods sold for the month reached C$751,356.

“It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” said PlantX CEO Julia Frank. “There are many other colorful growth opportunities on the horizon, and we’re confident that our financial trajectory will reflect the remarkable and increasing value our company brings to the plant-based industry.”

PlantX Life stated that its January numbers surpassed its December 2020 gross revenues of $1,029,883, which were achieved during a highly dynamic holiday season. “This was surpassed by January 2021’s revenue, which exceeded management’s expectations given that e-commerce sales were expected to be slower following the holiday season,” the announcement noted. “This success during one of the slowest e-commerce periods of the year highlights the tremendous impact the company continues to have in the plant-based marketplace.” The announcement stated that the company’s growth reflects its commitment to meet consumer demand and continues to be driven by its innovative partnerships as well as its marketing and branding efforts.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, PlantX currently has plans to expand its product lines to include cosmetics, clothing and its own water brand.

In addition, the company uses its digital platform to build a community of like-minded consumers and to provide education. Its successful enterprise is being built and fortified through partnerships with top nutritionists, chefs and brands. For example, the company offers 20 unique pre-made meals designed by top chefs and nutritionists. These healthy meals are offered at extremely competitive prices with fast shipping and round-the-clock convenience.

The company’s commitment to customer service is the driving force behind its e-commerce platform, with innovative thinking driving its operation; the PlantX team is constantly envisioning new ways to collaborate with local restaurateurs and entrepreneurs to bring PlantX to the world. PlantX is committed to eliminating the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

To learn more about this company, visit www.PlantX.com, www.PlantX.ca and www.Investor.PlantX.com and view the PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF